

Cover Story
Free
At a meeting of the NCI Board of Scientific Advisors March 29, NCI officials had good news to report:
In Brief


Drugs & Targets
Trending Stories
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Trump’s tariffs will likely affect cancer drugs and devices—and may deepen drug shortages
- The University of Rochester Wilmot Cancer Institute earns NCI Cancer Center designation